2872 550

Cited 0 times in

강박장애의 약물치료 전략

Other Titles
 Pharmacotherapeutic Strategy for Obsessive-Compulsive Disorder 
Authors
 김세주  ;  권준수  ;  김찬형 
Citation
 Korean Journal of Psychopharmacology (대한정신약물학회지), Vol.16(3) : 197-207, 2005 
Journal Title
Korean Journal of Psychopharmacology(대한정신약물학회지)
ISSN
 1017-5717 
Issue Date
2005
MeSH
Obsessive-compulsive disorder ; Treatment guideline ; Algorithm
Keywords
Obsessive-compulsive disorder ; Treatment guideline ; Algorithm
Abstract
Obsessive-compulsive disorder (OCD) has a lifetime prevalence of approximately 2-3%. Until relatively recently, effective treatments for OCD were lacking. Fortunately, over the past decades, the availability of serotonin reuptake inhibitors (SRIs) and behavioral treatments using exposure-response prevention techniques has altered the outlook for patients suffering from OCD. But, treating OCD with medication still requires a blend of science and art. SRIs provide clinically significant relief to most patients, but they are not effective in all patients. Because significant number of patient with OCD do not respond to adequate trials of SRIs, other treatment options such as augmentation, switching, combination, or neurosurgical and device-based approaches may be needed. In this paper, the first-line treatment options and several alternative treatment options for OCD were reviewed. Finally, we reviewed several treatment guidelines and algorithm for OCD introduced previously by other researchers. We have a plan to develop Korean treatment algorithm for OCD based on expert's opinions. Also, we hope to use this algorithm for OCD in the clinical setting in near future.
Files in This Item:
T200500648.pdf Download
DOI
OAK-2005-03979
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Psychiatry (정신과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Se Joo(김세주) ORCID logo https://orcid.org/0000-0002-5438-8210
Kim, Chan Hyung(김찬형)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/150976
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links